Pro Medicus Limited (PME) is involved in the development and supply of healthcare imaging software, Radiology Information System (RIS) software and services to hospitals, diagnostic imaging groups and other related health entities in Australia, North America and Europe.
Find out what a historical investment in Pro Medicus Limited would be worth today using our PME stock calculator.
Buying PME shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Pro Medicus Limited in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in PME
What is the ticker symbol of Pro Medicus Limited?
The ticker symbol for Pro Medicus Limited is PME.
How much is one share of PME?
One share of PME is valued at $187.76 as of 21 November 2026.
What is the market capitalisation of Pro Medicus Limited PME?
As of 21 November 2026 Pro Medicus Limited has a market cap of $19.61B.
Does PME pay dividends?
Yes, PME does pay dividends.
What is the dividend yield for PME?
The dividend yield for PME is 0.37% as of 21 November 2026.
How much dividends does PME pay?
The most recent PME dividend distribution paid $0.37 per share on 29 September 2026.
What is the PME ex-dividend date?
The ex-dividend date of PME was 07 September 2026.
What is the P/E ratio of PME?
The Price to Earnings ratio of PME is 75.93.
What is the Earnings Per Share of PME?
The Earnings Per Share of PME is $2.54.
What is the 52-week high for Pro Medicus Limited stock?
The Pro Medicus Limited 52-week high stock price is $272.85.
What is the 52-week low for Pro Medicus Limited stock?
The Pro Medicus Limited 52-week low stock price is $107.75.
Can I buy PME shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PME shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.